Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
1997 1
1998 2
2018 1
2019 1
2020 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Yaniv I, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chan GCF, Ruud E, Schroeder H, Beck Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN. Ladenstein R, et al. Among authors: michon jm. Lancet Oncol. 2018 Dec;19(12):1617-1629. doi: 10.1016/S1470-2045(18)30578-3. Epub 2018 Nov 12. Lancet Oncol. 2018. PMID: 30442501 Clinical Trial.
The Participatory Approach: A Specific French Organizational Model at the Department Level to Serve the Quality of Work Life of Healthcare Providers and the Quality of Care in Pediatric Oncology.
Lejeune J, Fouquereau E, Chênevert D, Coillot H, Chevalier S, Gillet N, Michon JM, Gandemer V, Colombat P. Lejeune J, et al. Among authors: michon jm. Cancer Manag Res. 2021 Mar 25;13:2763-2771. doi: 10.2147/CMAR.S284439. eCollection 2021. Cancer Manag Res. 2021. PMID: 33790650 Free PMC article.
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
Castleberry RP, Pritchard J, Ambros P, Berthold F, Brodeur GM, Castel V, Cohn SL, De Bernardi B, Dicks-Mireaux C, Frappaz D, Haase GM, Haber M, Jones DR, Joshi VV, Kaneko M, Kemshead JT, Kogner P, Lee RE, Matthay KK, Michon JM, Monclair R, Roald BR, Seeger RC, Shaw PJ, Shuster JJ, et al. Castleberry RP, et al. Among authors: michon jm. Eur J Cancer. 1997 Oct;33(12):2113-6. doi: 10.1016/s0959-8049(97)00202-5. Eur J Cancer. 1997. PMID: 9516864 Review. No abstract available.
Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1).
Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Ash S, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chi Fung Chan G, Ruud E, Schroeder H, Beck-Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN. Ladenstein R, et al. Among authors: michon jm. Cancers (Basel). 2020 Jan 28;12(2):309. doi: 10.3390/cancers12020309. Cancers (Basel). 2020. PMID: 32013055 Free PMC article.
High dose chemotherapy and autologous hematopoietic cell transplantation for Wilms tumor: a study of the European Society for Blood and Marrow Transplantation.
Spreafico F, Dalissier A, Pötschger U, Locatelli F, Michon JM, Peters C, Bader P, Bisogno G, Yeomanson D, Willasch A, van den Heuvel Eibrink M, Graf N, Dallorso S; EBMT Paediatric Diseases Working Party. Spreafico F, et al. Among authors: michon jm. Bone Marrow Transplant. 2020 Feb;55(2):376-383. doi: 10.1038/s41409-019-0661-7. Epub 2019 Sep 18. Bone Marrow Transplant. 2020. PMID: 31534191
An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma.
Michon JM, Hartmann O, Bouffet E, Meresse V, Coze C, Rubie H, Bordigoni P, Cattiaux E, Ward N, Bernard JL, Lemerle J, Zucker JM, Philip T. Michon JM, et al. Eur J Cancer. 1998 Jun;34(7):1063-9. doi: 10.1016/s0959-8049(98)00061-6. Eur J Cancer. 1998. PMID: 9849455 Clinical Trial.